Odile Mejan-Letourneur

Title: Odile Mejan-Letourneur: Innovator in Medical Diagnostics

Introduction

Odile Mejan-Letourneur is a prominent inventor based in Lyons, France. She has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of Lyme borreliosis and colorectal cancer. With a total of 5 patents to her name, her work has had a substantial impact on healthcare.

Latest Patents

Among her latest patents, Mejan-Letourneur has developed proteins used for the diagnosis of Lyme borreliosis. This innovation includes chimera proteins that consist of at least one sequence of a DbpA protein and at least one sequence of an OspC protein from selected species. Additionally, she has created a method and a kit for the in vitro diagnosis of Lyme borreliosis utilizing these proteins. Another significant patent involves a method for assaying leukocyte elastase inhibitor for the in vitro diagnosis of colorectal cancer. This method determines the presence of the Leukocyte Elastase Inhibitor tumor marker in biological samples from patients suspected of having colorectal cancer. It is designed for early diagnosis, screening, therapeutic follow-up, prognosis, and relapse diagnosis related to colorectal cancer.

Career Highlights

Mejan-Letourneur is currently associated with bioMérieux, Inc., a company known for its expertise in in vitro diagnostics. Her work at bioMérieux has allowed her to focus on innovative solutions that enhance diagnostic accuracy and patient care.

Collaborations

Throughout her career, Mejan-Letourneur has collaborated with notable colleagues, including Lionel Levet and Corinne Beaulieu. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Odile Mejan-Letourneur is a distinguished inventor whose work in medical diagnostics continues to influence the field. Her innovative patents and contributions to healthcare demonstrate her commitment to improving patient outcomes.